Pablo Sierra González, Phd Email & Phone Number

Madrid, Es

Spain

Barcelona, Catalonia, Spain

Barcelona, Catalonia, Spain

Cambridge, England, United Kingdom

Cambridge, England, United Kingdom

• Acted as Blueprint’s ambassador and cross-functionally led the main activities for pralsetinib and avapritinib in the UK, The Netherlands and Scandinavia in line with the company’s goals and strategy while liaising with global medical affairs, clinical operations, clinical development and market access teams to build the company’s footprint and its positioning against competitors• Gathered country- and disease-specific insights about standard of care, patient pathways and referral… Show more • Acted as Blueprint’s ambassador and cross-functionally led the main activities for pralsetinib and avapritinib in the UK, The Netherlands and Scandinavia in line with the company’s goals and strategy while liaising with global medical affairs, clinical operations, clinical development and market access teams to build the company’s footprint and its positioning against competitors• Gathered country- and disease-specific insights about standard of care, patient pathways and referral networks to support the pipeline’s clinical development through strategic site selection and improved patient identification for Blueprint’s clinical studies• Mapped and built a strong international network of top-tier KOLs (oncologists, pathologists, clin. scientists) that led to a better understanding of the current standards and gaps for potential opportunities in the molecular testing and precision medicine landscape• Acted as the main point of contact for clinical and scientific enquiries related to Blueprint’s pipeline and associated projects, such as compassionate use programs (CUP), congress sponsorships, investigator sponsored trials (IST), advisory boards and screening agreements, among others• Participated and executed market access plans through engagement with KOLs and Country Medicine Agencies to prepare, present and submit applications for in-country drug reimbursement Show less

Cambridge, United Kingdom

Cambridge, United Kingdom

• Field-based MSL focused on bringing KOL and HCP awareness on the latest scientific studies/guidelines (i.e. NICE / IMWG) linked to company´s products in the field of diagnostics• Mapped KOLs within the NHS and the private sector relevant for the company and future product development• Presented scientific and clinical data regularly to KOLs and other HCPs about diagnosis, monitoring and prognosis of patients with multiple myeloma and related monoclonal gammopathies • Worked in a… Show more • Field-based MSL focused on bringing KOL and HCP awareness on the latest scientific studies/guidelines (i.e. NICE / IMWG) linked to company´s products in the field of diagnostics• Mapped KOLs within the NHS and the private sector relevant for the company and future product development• Presented scientific and clinical data regularly to KOLs and other HCPs about diagnosis, monitoring and prognosis of patients with multiple myeloma and related monoclonal gammopathies • Worked in a cross-functional team alongside marketing and sales by providing necessary insights from the field to improve product development and define the commercial strategy Show less

Glasgow, Reino Unido

PhD focused on Combination Therapies in Solid Tumours.• Worked in a fast-paced, high pressure and changing environment in an autonomous manner.• Developed a translational research project that led to the discovery of a new anti-cancer agent with strong potential for combination with regular chemotherapy in solid tumours from lung, ovarian, breast and pancreatic cancer. • Built strong relationships and cross-functional collaborations with Thought Leaders, the team of… Show more PhD focused on Combination Therapies in Solid Tumours.• Worked in a fast-paced, high pressure and changing environment in an autonomous manner.• Developed a translational research project that led to the discovery of a new anti-cancer agent with strong potential for combination with regular chemotherapy in solid tumours from lung, ovarian, breast and pancreatic cancer. • Built strong relationships and cross-functional collaborations with Thought Leaders, the team of preclinical studies, drug discovery units and business development department which successfully led to a £200.000 grant funding and a patent application.• Reported progress on each study to internal and external collaborators and discussed the strategy to meet the expectations of all partners/departments involved in those projects. • Presented complex scientific information at weekly internal meetings, seminars and international conferences to a variety of audiences.• In-depth analysis of patient’s clinical samples from renal, colorectal, breast, prostate and ovarian cancer for possibility of treatment with the new combination therapy.• Gained knowledge about the pharmaceutical environment and the importance of business results by working in a laboratory in collaboration with Astellas Pharma.• Extensive writing experience by the preparation of scientific reports and abstracts.• Collaborated on multiple projects that led to two shared publications, • Lectured in the MSc. of Cancer Science, University of Glasgow. Show less

Santiago De Compostela Y Alrededores, España

Project based on building an specific and reliable source of information for scientists and clinicians to improve patient diagnosis of two rare diseases.• Analytical mindset as proven by the ability to compile, verify and organise large amounts of complex patients' genetic and clinical data.• Strong collaborative relationships built throughout this period with the LOVD development team to improve the software and management the free-access data available in the… Show more Project based on building an specific and reliable source of information for scientists and clinicians to improve patient diagnosis of two rare diseases.• Analytical mindset as proven by the ability to compile, verify and organise large amounts of complex patients' genetic and clinical data.• Strong collaborative relationships built throughout this period with the LOVD development team to improve the software and management the free-access data available in the databases.• Fast-learner and autodidact. Show less

Madrid Y Alrededores, España

Drug discovery/testing project to study the effectiveness of pharmacological chaperones as a clinical approach for treatment of Congenital Disorders of Glycosylation (CDG).• Excellent project management skills by developing a drug discovery and drug testing project with promising applications in clinical trials.• Excellent team player as demonstrated by succesful collaborations with internal and external scientists of the patient diagnosis department for rare diseases.

Pontevedra

• Expertise in the basics of genetic improvement of plants for commercial applications.

Doctor Of Philosophy (Phd), Cancer Research

Master'S Degree, Biomedical Research

Activities and Societies: Master thesis in Galician Public Foundation of Genome Medicine

Bachelor Of Science (Bsc), Biochemistry

Activities and Societies: Undergraduate research project in Molecular Biology Center Severo Ochoa (CBMSO-CSIC)

Bachelor Of Science (Bsc), Biology (Speciality Of Genetic)

Activities and Societies: Scholarship for a year in Madrid.

Bachelor Of Science (Bsc), Biology